Outcomes After Fecal Microbiota Transplantation in Combination With Bezlotoxumab for Inflammatory Bowel Disease and Recurrent Clostridioides difficile Infection.

已完结 20 由 77 发布于 2024/12/25 11:16:13

DOI:10.14309/ajg.0000000000002770
作者：Jessica R Allegretti,?Jordan Axelrad,?Rahul S Dalal,?Colleen R Kelly,?Ari Grinspan,?Monika Fischer
文献类型：期刊论文
补充材料：只需要正文

Wolters Kluwer Ovid

Abstract：Abstract: Fecal microbiota transplantation (FMT) prevents recurrent Clostridioides difficile infections (rCDI) in patients with inflammatory bowel disease. Bezlotoxumab is also indicated to

应助信息

21小时前

帝企鹅

202412251357115497096.pdf 已采纳

23小时前

Book学术机器人

2024/12/25 11:16:13 未找到该文献，机器人已退出，请等待人工下载

2024/12/25 11:16:13 Book学术AI机器人收到请求，开始寻找文献

2024/12/25 11:16:13 已向机器人发送请求

23小时前

77 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileySmart Design of Targeted Drug Delivery System for Precise Drug Delivery and Visual Treatment of Brain Gliomas.